These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 29072131)

  • 1. Cancer stem cells and differentiation therapy.
    Jin X; Jin X; Kim H
    Tumour Biol; 2017 Oct; 39(10):1010428317729933. PubMed ID: 29072131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Opportunities and Challenges to Defeat Cancer Stem Cells.
    Ramos EK; Hoffmann AD; Gerson SL; Liu H
    Trends Cancer; 2017 Nov; 3(11):780-796. PubMed ID: 29120754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
    Fanale D; Barraco N; Listì A; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation, identification, and characterization of cancer stem cells: A review.
    Abbaszadegan MR; Bagheri V; Razavi MS; Momtazi AA; Sahebkar A; Gholamin M
    J Cell Physiol; 2017 Aug; 232(8):2008-2018. PubMed ID: 28019667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.
    Keyvani-Ghamsari S; Khorsandi K; Rasul A; Zaman MK
    Clin Epigenetics; 2021 May; 13(1):120. PubMed ID: 34051847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cells stemness: A doorstep to targeted therapy.
    Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents.
    Zhou HM; Zhang JG; Zhang X; Li Q
    Signal Transduct Target Ther; 2021 Feb; 6(1):62. PubMed ID: 33589595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer stem cells as a possible source of tumor initiation and progression].
    Puchinskaya MV
    Vopr Onkol; 2016; 62(1):14-23. PubMed ID: 30444327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-renewal signaling pathways in breast cancer stem cells.
    Nalla LV; Kalia K; Khairnar A
    Int J Biochem Cell Biol; 2019 Feb; 107():140-153. PubMed ID: 30593953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells: the promise and the potential.
    Ajani JA; Song S; Hochster HS; Steinberg IB
    Semin Oncol; 2015 Apr; 42 Suppl 1():S3-17. PubMed ID: 25839664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer stem cells: Biology and therapeutic implications.
    Butti R; Gunasekaran VP; Kumar TVS; Banerjee P; Kundu GC
    Int J Biochem Cell Biol; 2019 Feb; 107():38-52. PubMed ID: 30529656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Tumor Initiating Cells through Inhibition of Cancer Testis Antigens and Notch Signaling: A Hypothesis.
    Colombo M; Mirandola L; Reidy A; Suvorava N; Konala V; Chiaramonte R; Grizzi F; Rahman RL; Jenkins MR; Nugyen DD; Dalhbeck S; Cobos E; Figueroa JA; Chiriva-Internati M
    Int Rev Immunol; 2015 Mar; 34(2):188-99. PubMed ID: 25901861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of stem cells-related signaling pathways in response to doxorubicin treatment in Hs578T triple-negative breast cancer cells.
    Tudoran O; Soritau O; Balacescu L; Visan S; Barbos O; Cojocneanu-Petric R; Balacescu O; Berindan-Neagoe I
    Mol Cell Biochem; 2015 Nov; 409(1-2):163-76. PubMed ID: 26187676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise Review: Stem Cells in Pancreatic Cancer: From Concept to Translation.
    Raj D; Aicher A; Heeschen C
    Stem Cells; 2015 Oct; 33(10):2893-902. PubMed ID: 26202953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
    Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
    J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells.
    Jung EH; Lee HN; Han GY; Kim MJ; Kim CW
    Cell Biochem Funct; 2016 Apr; 34(3):149-57. PubMed ID: 26923195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cell targeted therapies.
    Testa U; Pelosi E; Castelli G
    Ann Ist Super Sanita; 2020; 56(3):336-350. PubMed ID: 32959800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.
    Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H
    Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of cancer stem cells in the treatment of cancer.
    Pan CX; Zhu W; Cheng L
    Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do stem-like cells play a role in drug resistance of sarcomas?
    Honoki K
    Expert Rev Anticancer Ther; 2010 Feb; 10(2):261-70. PubMed ID: 20132001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.